1. Home
  2. ANAB vs WABC Comparison

ANAB vs WABC Comparison

Compare ANAB & WABC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

ANAB

AnaptysBio Inc.

N/A

Current Price

$64.67

Market Cap

1.3B

Sector

Health Care

ML Signal

N/A

Logo Westamerica Bancorporation

WABC

Westamerica Bancorporation

N/A

Current Price

$49.94

Market Cap

1.3B

Sector

Finance

ML Signal

N/A

Company Overview

Basic Information
Metric
ANAB
WABC
Founded
2005
1972
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Major Banks
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
1.3B
1.3B
IPO Year
2015
1994

Fundamental Metrics

Financial Performance
Metric
ANAB
WABC
Price
$64.67
$49.94
Analyst Decision
Strong Buy
Hold
Analyst Count
10
2
Target Price
$68.10
$52.50
AVG Volume (30 Days)
442.0K
143.6K
Earning Date
05-25-2026
04-16-2026
Dividend Yield
N/A
3.67%
EPS Growth
91.02
N/A
EPS
N/A
3.40
Revenue
$234,603,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$43.04
N/A
P/E Ratio
N/A
$14.73
Revenue Growth
157.01
N/A
52 Week Low
$15.32
$42.00
52 Week High
$63.47
$53.48

Technical Indicators

Market Signals
Indicator
ANAB
WABC
Relative Strength Index (RSI) 68.28 40.77
Support Level $43.67 $46.33
Resistance Level N/A $50.18
Average True Range (ATR) 3.61 1.34
MACD 0.67 -0.30
Stochastic Oscillator 88.63 34.60

Price Performance

Historical Comparison
ANAB
WABC

About ANAB AnaptysBio Inc.

AnaptysBio Inc is a clinical-stage biotechnology company. The company is focused on developing antibody product candidates for unmet medical needs in inflammation and immuno-oncology. The company is developing immune cell modulating antibodies, including two wholly owned checkpoint agonists in clinical-stage development, for autoimmune and inflammatory diseases; rosnilimab, PD-1 agonist in a Phase 2b trial for the treatment of moderate-to-severe rheumatoid arthritis (RA) and a Phase 2 trial for the treatment of moderate-to-severe ulcerative colitis (UC); and ANB032, BTLA agonist, in a Phase 2b trial for the treatment of moderate-to-severe atopic dermatitis (AD).

About WABC Westamerica Bancorporation

Westamerica Bancorp is based in San Rafael, California. Westamerica Bancorporation runs a regional community bank and has approximately $7.5 billion in assets. The banks' net revenue is generated by net interest income. Deposit service charges make up the noninterest income sources. The bank focuses mostly on commercial clients, such as smaller businesses. Its footprint encompasses central and northern California, extending north of San Francisco to Mendocino and Lake counties, south to Kern County in central California and all the way east to Nevada County.

Share on Social Networks: